Binge Eating Disorders Epidemiology Forecast

DelveInsight's "Binge (Eating) Disorders - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Binge (Eating) Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2019-2032

Binge (Eating) Disorders Understanding

The DelveInsight Binge (Eating) Disorders epidemiology report gives a thorough understanding of the Binge (Eating) Disorders by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Binge (Eating) Disorders in the US, Europe, and Japan. The report covers the detailed information of the Binge (Eating) Disorders epidemiology scenario in seven major countries (US, EU5, and Japan).

Binge (Eating) Disorders Epidemiology Perspective by DelveInsight

The Binge (Eating) Disorders epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Binge (Eating) Disorders epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Binge (Eating) Disorders epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Binge (Eating) Disorders Detailed Epidemiology Segmentation

The Binge (Eating) Disorders epidemiology covered in the report provides historical as well as forecasted Binge (Eating) Disorders epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

 

The DelveInsight Binge (Eating) Disorders report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

  • The Binge (Eating) Disorders report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Binge (Eating) Disorders Epidemiology Report and Model provide an overview of the global trends of Binge (Eating) Disorders in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight into the historical and forecasted patient pool of Binge (Eating) Disorders in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps recognize the growth opportunities in the 7MM for the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Binge (Eating) Disorders
  • The report provides the segmentation of the Binge (Eating) Disorders epidemiology

Report Highlights

  • 11-year Forecast of Binge (Eating) Disorders epidemiology
  • 7MM Coverage
  • Prevalent and Diagnosed Cases of Binge (Eating) Disorders
  • Cases of Binge (Eating) Disorders by Mutation Types
  • Binge (Eating) Disorders Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Binge (Eating) Disorders?
  • What are the key findings pertaining to the Binge (Eating) Disorders epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
  • What would be the total number of patients of Binge (Eating) Disorders across the 7MM during the forecast period (2019-2032)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
  • What is the disease risk, burden and unmet needs of Binge (Eating) Disorders?
  • What are the currently available treatments of Binge (Eating) Disorders?

Reasons to buy

The Binge (Eating) Disorders Epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Binge (Eating) Disorders market
  • Quantify patient populations in the global Binge (Eating) Disorders market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Binge (Eating) Disorders therapeutics in each of the markets covered
  • Understand the magnitude of Binge (Eating) Disorders population by its epidemiology
  • The Binge (Eating) Disorders Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Binge (Eating) Disorders

3. Binge (Eating) Disorders: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Binge (Eating) Disorders Epidemiology Scenario in the 7MM (2019- 2032)

5.4. United States Epidemiology

5.4.1. Binge (Eating) Disorders Epidemiology Scenario in the United States (2019- 2032)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Binge (Eating) Disorders Epidemiology Scenario in Germany (2019- 2032)

5.5.2. France Epidemiology

5.5.2.1. Binge (Eating) Disorders Epidemiology Scenario in France (2019- 2032)

5.5.3. Italy Epidemiology

5.5.3.1. Binge (Eating) Disorders Epidemiology Scenario in Italy (2019- 2032)

5.5.4. Spain Epidemiology

5.5.4.1. Binge (Eating) Disorders Epidemiology Scenario in Spain (2019- 2032)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Binge (Eating) Disorders Epidemiology Scenario in the United Kingdom (2019-2032)

5.6. Japan Epidemiology

5.6.1. Binge (Eating) Disorders Epidemiology Scenario in Japan (2019- 2032)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Binge (Eating) Disorders Treatment and Management

6.2. Binge (Eating) Disorders Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

List of Tables

Table 1:  Binge (Eating) Disorders Epidemiology in 7MM (2019-2032)

Table 2: Binge (Eating) Disorders Diagnosed and Treatable Cases in 7MM (2019-2032)

Table 3: Binge (Eating) Disorders Epidemiology in the United States (2019-2032)

Table 4: Binge (Eating) Disorders Diagnosed and Treatable Cases in the United States (2019-2032)

Table 5: Binge (Eating) Disorders Epidemiology in Germany (2019-2032)

Table 6: Binge (Eating) Disorders Diagnosed and Treatable Cases in Germany (2019-2032)

Table 7: Binge (Eating) Disorders Epidemiology in France (2019-2032)

Table 8: Binge (Eating) Disorders Diagnosed and Treatable Cases in France (2019-2032)

Table 9: Binge (Eating) Disorders Epidemiology in Italy (2019-2032)

Table 10: Binge (Eating) Disorders Diagnosed and Treatable Cases in Italy (2019-2032)

Table 11: Binge (Eating) Disorders Epidemiology in Spain (2019-2032)

Table 12: Binge (Eating) Disorders Diagnosed and Treatable Cases in Spain (2019-2032)

Table 13: Binge (Eating) Disorders Epidemiology in the United Kingdom (2019-2032)

Table 14: Binge (Eating) Disorders Diagnosed and Treatable Cases in the United Kingdom (2019-2032)

Table 15: Binge (Eating) Disorders Epidemiology in Japan (2019-2032)

Table 16: Binge (Eating) Disorders Diagnosed and Treatable Cases in Japan (2019-2032)

List of Figures

Figure 1 Binge (Eating) Disorders Epidemiology in 7MM (2019-2032)

Figure 2 Binge (Eating) Disorders Diagnosed and Treatable Cases in 7MM (2019-2032)

Figure 3 Binge (Eating) Disorders Epidemiology in the United States (2019-2032)

Figure 4 Binge (Eating) Disorders Diagnosed and Treatable Cases in the United States (2019-2032)

Figure 5  Binge (Eating) Disorders Epidemiology in Germany (2019-2032)

Figure 6  Binge (Eating) Disorders Diagnosed and Treatable Cases in Germany (2019-2032)

Figure 7  Binge (Eating) Disorders Epidemiology in France (2019-2032)

Figure 8 Binge (Eating) Disorders Diagnosed and Treatable Cases in France (2019-2032)

Figure 9 Binge (Eating) Disorders Epidemiology in Italy (2019-2032)

Figure 10 Binge (Eating) Disorders Diagnosed and Treatable Cases in Italy (2019-2032)

Figure 11 Binge (Eating) Disorders Epidemiology in Spain (2019-2032)

Figure 12 Binge (Eating) Disorders Diagnosed and Treatable Cases in Spain (2019-2032)

Figure 13 Binge (Eating) Disorders Epidemiology in the United Kingdom (2019-2032)

Figure 14 Binge (Eating) Disorders Diagnosed and Treatable Cases in the United Kingdom (2019-2032)

Figure 15 Binge (Eating) Disorders Epidemiology in Japan (2019-2032)

Figure 16 Binge (Eating) Disorders Diagnosed and Treatable Cases in Japan (2019-2032)

*The table of contents is not exhaustive; will be provided in the final report

Forward to Friend

Need A Quote